XGN - Exagen - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

XGN is currently covered by 2 analysts with an average price target of $12.24. This is a potential upside of $6.53 (114.36%) from yesterday's end of day stock price of $5.71.

Exagen's activity chart (see below) currently has 23 price targets and 20 ratings on display. The stock rating distribution of XGN is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 21.03% with an average time for these price targets to be met of 209.5 days.

Highest price target for XGN is $8, Lowest price target is $7, average price target is $7.5.

Most recent stock forecast was given by ROSS OSBORN from CANTOR FITZGERALD on 13-Jan-2025. First documented stock forecast 01-Jun-2020.

Currently out of the existing stock ratings of XGN, 6 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$8

$1.98 (32.89%)

$7

3 months 26 days ago
(13-Jan-2025)

3/6 (50%)

$4.88 (156.41%)

503

Buy

$7

$0.98 (16.28%)

$7

4 months 6 days ago
(03-Jan-2025)

3/7 (42.86%)

$3.42 (95.53%)

124

Buy

$5

$-1.02 (-16.94%)

$7

2 years 1 months 17 days ago
(22-Mar-2023)

1/3 (33.33%)

$2.76 (123.21%)

630

Hold

$17

2 years 9 months 4 days ago
(05-Aug-2022)

0/3 (0%)

$12.17 (251.97%)

Buy

$16

$12.42 (346.93%)

3 years 1 months 16 days ago
(23-Mar-2022)

0/2 (0%)

$7.25 (82.86%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is XGN (Exagen) average time for price targets to be met?

On average it took 209.5 days on average for the stock forecasts to be realized with a an average price target met ratio 21.03

Which analyst has the current highest performing score on XGN (Exagen) with a proven track record?

KYLE MIKSON

Which analyst has the current lower performing score on XGN (Exagen) with a proven track record?

DOUG SCHENKEL

Which analyst has the most public recommendations on XGN (Exagen)?

Kyle Mikson works at CANACCORD and has 12 price targets and 7 ratings on XGN

Which analyst is the currently most bullish on XGN (Exagen)?

Doug Schenkel with highest potential upside - $24.38

Which analyst is the currently most reserved on XGN (Exagen)?

Mark Massaro with lowest potential downside - -$1.02

Exagen in the News

Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares

CARLSBAD, Calif., May 09, 2025 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that it has completed the sale of an additional 502,500 shares of its common stock at a public offering price of $5.25 per share on May 8, 2025, pursuant to the full exercise of the...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?